(Total Views: 304)
Posted On: 02/20/2019 10:38:32 AM
Post# of 72446
I think you're underestimating the outstanding ABSSSI phase 2b, QIDP designation, heady Cubicin buyout, and near-term partnership and phase 3 prospects in December 2014.
Kevetrin was low on the list of stock price drivers at that time.
Kevetrin was low on the list of stock price drivers at that time.
(0)
(0)
